Lactobacillus helveticus R0052 and Increased Head Circumference

Doses used in studies

Time to effect

Median: 8 weeks · IQR 8 weeks–8 weeks · Range 8 weeks–8 weeks — Reported in 1 of 1 study

Safety in these studies

adverse eventsNo significant difference
Total number of AEs recorded was equivalent in all groups.
from: Safety and tolerance of three probiotic strains in healthy infants: a multi-centre randomi
growth measuresNo significant difference
The results showed that changes in growth (weight, height and head circumference) were equivalent in all 4 groups.
from: Safety and tolerance of three probiotic strains in healthy infants: a multi-centre randomi
Overall tolerabilityReported
Thus, the use of B. infantis R0033, L. helveticus R0052 and B. bifidum R0071 in infancy is safe, and well tolerated.
from: Safety and tolerance of three probiotic strains in healthy infants: a multi-centre randomi
serious adverse eventReported
No SAEs were reported.
from: Safety and tolerance of three probiotic strains in healthy infants: a multi-centre randomi

1 of 1 paper

Safety and tolerance of three probiotic strains in healthy infants: a multi-centre randomized, double-blind, placebo-controlled trial.